The Italian Medicines Agency (AIFA) approved the administration of the vaccine from the American pharmaceutical company Moderna for adolescents between 12 and 17 years old, who until now received Pfizer.
The AIFA Scientific Technical Commission reported that it has followed the line of opinion expressed by the European Medicines Agency (EMA) and has considered that the available data demonstrate the efficacy and safety of the vaccine even for subjects included in this group of age.
Italy is studying whether the Pfizer and Moderna vaccines can also be inoculated to children between the
6 months and 12 years, but health authorities have warned that it takes time to carry out the tests.
This country has already supplied 66,469,852 doses and 31 million people have received the full regimen, the equivalent of 57.4% of the population over 12 years of age.